PL3745128T3 - Test odpowiedzi immunologicznej pośredniczony przez komórki - Google Patents
Test odpowiedzi immunologicznej pośredniczony przez komórkiInfo
- Publication number
- PL3745128T3 PL3745128T3 PL20179689.3T PL20179689T PL3745128T3 PL 3745128 T3 PL3745128 T3 PL 3745128T3 PL 20179689 T PL20179689 T PL 20179689T PL 3745128 T3 PL3745128 T3 PL 3745128T3
- Authority
- PL
- Poland
- Prior art keywords
- cell
- immune response
- mediated immune
- response assay
- assay
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/555—Interferons [IFN]
- G01N2333/57—IFN-gamma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261746965P | 2012-12-28 | 2012-12-28 | |
| EP13167355 | 2013-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3745128T3 true PL3745128T3 (pl) | 2025-09-22 |
Family
ID=51019570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20179689.3T PL3745128T3 (pl) | 2012-12-28 | 2013-12-20 | Test odpowiedzi immunologicznej pośredniczony przez komórki |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10564150B2 (pl) |
| EP (4) | EP2939025B1 (pl) |
| JP (5) | JP6431484B2 (pl) |
| CN (2) | CN105051537B (pl) |
| AU (3) | AU2013370928B2 (pl) |
| CY (1) | CY1123265T1 (pl) |
| DK (2) | DK2939025T3 (pl) |
| ES (2) | ES3031233T3 (pl) |
| HU (1) | HUE038527T2 (pl) |
| LT (1) | LT2939025T (pl) |
| PL (1) | PL3745128T3 (pl) |
| PT (1) | PT2939025T (pl) |
| SI (2) | SI3421997T1 (pl) |
| TR (1) | TR201809679T4 (pl) |
| WO (2) | WO2014100860A2 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3421997T1 (sl) | 2012-12-28 | 2020-10-30 | Cellestis Limited | Test celično posredovanega imunskega odziva |
| KR20170071507A (ko) * | 2014-10-23 | 2017-06-23 | 퀴아젠 사이언시스, 엘엘씨 | 펩티드 조성물 및 그의 용도 |
| GB201605210D0 (en) | 2016-03-29 | 2016-05-11 | Oxford Immunotec Ltd | Assay |
| CN117959415A (zh) | 2016-09-13 | 2024-05-03 | 阿勒根公司 | 非蛋白质梭菌毒素组合物 |
| WO2018213192A1 (en) * | 2017-05-15 | 2018-11-22 | University Of Miami | Materials and methods for subjects at risk for viral reactivation |
| JP7320645B1 (ja) | 2022-04-13 | 2023-08-03 | 株式会社アマダ | プレスブレーキ、及びプレスブレーキのテーブル駆動方法 |
| WO2024263622A1 (en) * | 2023-06-19 | 2024-12-26 | Immune Functional Diagnostics, Llc | Methods and assays for immune phenotyping |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US434010A (en) * | 1890-08-12 | Band-saw guide | ||
| US4018653A (en) | 1971-10-29 | 1977-04-19 | U.S. Packaging Corporation | Instrument for the detection of Neisseria gonorrhoeae without culture |
| US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
| US4424279A (en) | 1982-08-12 | 1984-01-03 | Quidel | Rapid plunger immunoassay method and apparatus |
| EP0229810B1 (en) * | 1985-07-09 | 1991-10-16 | Quadrant Bioresources Limited | Protection of proteins and the like |
| JP3187622B2 (ja) * | 1993-10-07 | 2001-07-11 | カネボウ株式会社 | リポソーム |
| IL121116A (en) * | 1997-06-19 | 2000-12-06 | Savyon Diagnostics Ltd | Stabilization of polypeptides for use in immunoassay procedures |
| PL202399B1 (pl) * | 1998-10-05 | 2009-06-30 | Pharmexa As | Zastosowanie adiuwanta i pierwszego analogu polipeptydowego antygenu związanego z komórką lub co najmniej jednego fragmentu kwasu nukleinowego kodującego epitop CTL pochodzący z antygenu polipeptydowego związanego z komórką lub niepatogennego mikroorganizmu lub wirusa, który niesie fragment kwasu nukleinowego, który koduje i wyraża co najmniej jeden epitop CTL pochodzący z antygenu polipeptydowego związanego z komórką, sposób selekcji immunogennego analogu antygenu polipeptydowego związanego z komórką, sposób wytwarzania komórki wytwarzającej analog an |
| CN1262131A (zh) * | 1999-01-29 | 2000-08-09 | 长春长生实业股份有限公司 | 海藻糖替代人血白蛋白保护微生物及微生物制剂 |
| SI1150712T1 (sl) * | 1999-02-05 | 2009-02-28 | Merck & Co Inc | Pripravek cepiva proti humanem papiloma virusu |
| FR2791895B1 (fr) * | 1999-03-23 | 2001-06-15 | Pasteur Merieux Serums Vacc | Utilisation de trehalose pour stabiliser un vaccin liquide |
| DE10031236A1 (de) | 2000-06-27 | 2002-01-10 | Qiagen Gmbh | Verwendung von Carbonsäuren und anderen Additiven in Kombination mit kationischen Verbindungen zur Stabilisierung von Nukleinsäuren in biologischen Materialien |
| AU2001278734A1 (en) | 2000-08-16 | 2002-02-25 | Takara Bio Inc. | Method of extensive culture of antigen-specific cytotoxic t cells |
| KR20020069239A (ko) * | 2000-11-07 | 2002-08-29 | 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 | 점막면역 조절제 및 그 용도 |
| US6602718B1 (en) | 2000-11-08 | 2003-08-05 | Becton, Dickinson And Company | Method and device for collecting and stabilizing a biological sample |
| ATE445839T1 (de) * | 2001-01-08 | 2009-10-15 | Us Gov Health & Human Serv | Latentes tuberkulose-diagnostisches antigen und verwendungsmethode |
| EP1372708B1 (en) * | 2001-02-13 | 2008-06-18 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY | Vaccine for transcutaneous immunization against travellers' diarrhoea |
| AU2002360499A1 (en) * | 2001-12-05 | 2003-06-17 | University Of Washington | Microfluidic device and surface decoration process for solid phase affinity binding assays |
| US7257086B2 (en) * | 2002-08-27 | 2007-08-14 | Terabeam Corporation | Method and system for effectuating network routing over primary and backup channels |
| AU2002952548A0 (en) * | 2002-11-08 | 2002-11-21 | Cellestis Limited | Diagnostic assay |
| JP3675800B2 (ja) * | 2003-03-31 | 2005-07-27 | 株式会社東芝 | 音声通話ソフトウェア、及び音声通話装置 |
| WO2004099771A1 (en) | 2003-05-08 | 2004-11-18 | Statens Serum Institut | A new specific epitope based immunological diagnosis of tuberculosis |
| EP1529536A1 (en) | 2003-11-05 | 2005-05-11 | Institut Pasteur | Immunogenic composition having improved immunostimulation capacity |
| DK2330121T3 (en) | 2004-06-02 | 2014-12-15 | Adalta Pty Ltd | Binding moieties based on shark IgNar domains |
| US20090155351A1 (en) * | 2005-10-04 | 2009-06-18 | Alk-Abello A/S | Solid Vaccine Formulation |
| BRPI0616879A2 (pt) * | 2005-10-04 | 2011-07-05 | Alk Abello As | formulação de vacina sólida |
| KR100784485B1 (ko) * | 2006-01-18 | 2007-12-11 | 한국과학기술연구원 | 생분해성 온도 감응성 폴리포스파젠계 하이드로젤, 그의제조방법 및 그의 용도 |
| DK2601969T3 (en) * | 2006-09-29 | 2016-04-18 | Takeda Vaccines Inc | Norovirus vaccine formulations |
| TW200833357A (en) * | 2006-10-20 | 2008-08-16 | Amgen Inc | Stable polypeptide formulations |
| US8871508B2 (en) | 2007-03-16 | 2014-10-28 | Cellestis Limited | Cell-mediated immune response assay and kits therefor |
| US20100317084A1 (en) | 2007-05-10 | 2010-12-16 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacteria comprising vectors for expression of nucleic acid sequences encoding antigens |
| US20100260791A1 (en) * | 2007-08-03 | 2010-10-14 | President And Fellows Of Harvard | Chlamydia antigens |
| GB0716070D0 (en) | 2007-08-17 | 2007-09-26 | Fusion Antibodies Ltd | Diagnostic method and kit |
| EP2106803A1 (en) | 2008-04-04 | 2009-10-07 | Fondazione Centro San Raffaele del Monte Tabor | Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients |
| US20110033377A1 (en) | 2008-04-23 | 2011-02-10 | Healthlinx Limited | Assay to detect a gynecological condition |
| CA2731854C (en) | 2008-07-25 | 2020-06-30 | Cellestis Limited | Measurement of cell-mediated immune response reactivity to detect or monitor a disease or condition |
| US20110131720A1 (en) * | 2009-12-09 | 2011-06-09 | David Franklin Dean | Wall Mounted Lift Chair |
| WO2011075773A1 (en) | 2009-12-23 | 2011-06-30 | Cellestis Limited | An assay for measuring cell-mediated immunoresponsiveness |
| JP5630637B2 (ja) * | 2010-02-26 | 2014-11-26 | 日立化成株式会社 | 感光性樹脂組成物 |
| BR112012027055B1 (pt) * | 2010-04-20 | 2019-09-17 | Octapharma Ag | Método para estabilizar uma proteína do plasma de sangue humano, composição, e uso da melezitose |
| WO2011146968A1 (en) * | 2010-05-28 | 2011-12-01 | Cellestis Limited | A diagnostic assay |
| EP2649455A1 (en) * | 2010-12-09 | 2013-10-16 | Hvidovre Hospital | A method for generating, storing, transporting, eluting and detecting clinical relevant information in plasma using filter paper |
| WO2012109167A1 (en) * | 2011-02-08 | 2012-08-16 | Integrated Biotherapeutics, Inc. | Immunogenic composition comprising alpha-hemolysin oligopeptides |
| JP6050811B2 (ja) * | 2011-06-24 | 2016-12-21 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | アルミニウムアジュバントを含むｈｐｖワクチン製剤およびその産生方法 |
| US9983207B2 (en) | 2011-06-29 | 2018-05-29 | Cellestis Limited | Cell mediated immune response assay with enhanced sensitivity |
| EP2690839B1 (en) | 2012-07-23 | 2018-09-26 | STMicroelectronics (Rousset) SAS | NFC apparatus capable to perform a contactless tag reading function |
| WO2014085713A1 (en) | 2012-11-30 | 2014-06-05 | The Methodist Hospital Research Institute | Methods and compositions for detecting tuberculosis |
| SI3421997T1 (sl) | 2012-12-28 | 2020-10-30 | Cellestis Limited | Test celično posredovanega imunskega odziva |
| CN107683291B (zh) | 2015-04-02 | 2021-11-19 | 英特维特国际股份有限公司 | 针对犬白介素-4受体α的抗体 |
-
2013
- 2013-12-20 SI SI201331782T patent/SI3421997T1/sl unknown
- 2013-12-20 PL PL20179689.3T patent/PL3745128T3/pl unknown
- 2013-12-20 ES ES20179689T patent/ES3031233T3/es active Active
- 2013-12-20 WO PCT/AU2013/001590 patent/WO2014100860A2/en not_active Ceased
- 2013-12-20 AU AU2013370928A patent/AU2013370928B2/en active Active
- 2013-12-20 JP JP2015549901A patent/JP6431484B2/ja active Active
- 2013-12-20 TR TR2018/09679T patent/TR201809679T4/tr unknown
- 2013-12-20 DK DK13869475.7T patent/DK2939025T3/en active
- 2013-12-20 PT PT138694757T patent/PT2939025T/pt unknown
- 2013-12-20 EP EP13869475.7A patent/EP2939025B1/en active Active
- 2013-12-20 CN CN201380065249.4A patent/CN105051537B/zh active Active
- 2013-12-20 WO PCT/AU2013/001509 patent/WO2014100853A1/en not_active Ceased
- 2013-12-20 ES ES13869475.7T patent/ES2677723T3/es active Active
- 2013-12-20 LT LTEP13869475.7T patent/LT2939025T/lt unknown
- 2013-12-20 HU HUE13869475A patent/HUE038527T2/hu unknown
- 2013-12-20 EP EP18168149.5A patent/EP3421997B1/en active Active
- 2013-12-20 EP EP20179689.3A patent/EP3745128B1/en active Active
- 2013-12-20 EP EP25177355.2A patent/EP4582807A3/en active Pending
- 2013-12-20 CN CN201910318768.6A patent/CN110118871A/zh active Pending
- 2013-12-20 SI SI201331110T patent/SI2939025T1/sl unknown
- 2013-12-20 DK DK18168149.5T patent/DK3421997T3/da active
- 2013-12-20 US US14/758,189 patent/US10564150B2/en active Active
-
2018
- 2018-11-02 JP JP2018207149A patent/JP2019013254A/ja not_active Withdrawn
-
2019
- 2019-07-02 AU AU2019204756A patent/AU2019204756B2/en active Active
-
2020
- 2020-01-03 US US16/733,950 patent/US12153042B2/en active Active
- 2020-03-31 JP JP2020062027A patent/JP7008739B2/ja active Active
- 2020-08-17 CY CY20201100766T patent/CY1123265T1/el unknown
-
2021
- 2021-06-01 AU AU2021203579A patent/AU2021203579A1/en not_active Abandoned
-
2022
- 2022-01-11 JP JP2022002061A patent/JP2022066193A/ja not_active Withdrawn
-
2023
- 2023-06-12 JP JP2023096197A patent/JP2023126213A/ja active Pending
-
2025
- 2025-01-10 US US19/016,630 patent/US20250369957A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2024011I1 (el) | Αντισωματα anti-fcrn | |
| EP2906241A4 (en) | IMPROVEMENT OF IMMUNE RESPONSE | |
| DK2858671T3 (da) | Antistofformulering | |
| DK2890397T3 (da) | Antiprolactinreceptor-antistofformulering | |
| DK2726883T4 (da) | Cellemedieret immunresponsanalyse med forbedret følsomhed | |
| DK2934584T3 (da) | Anti-gdf15-antistoffer | |
| EP2836960A4 (en) | BIOMETRIC DETECTION | |
| HRP20181646T1 (hr) | Konjugati pirolobenzodiazepin - anti-psma protutijela | |
| PT2878018T (pt) | Resumo | |
| EP2902071A4 (en) | INTERCONNECTS | |
| PT2819623T (pt) | Resumo | |
| DK2854632T3 (da) | Perception loss detection | |
| PT2831109T (pt) | Resumo | |
| FR2998638B1 (fr) | Raccord | |
| EP2900475A4 (en) | Drop detection | |
| EP2929435A4 (en) | RAID INSPECTOR | |
| EP2878951A4 (en) | ANALYTICAL DEVICE | |
| PL3745128T3 (pl) | Test odpowiedzi immunologicznej pośredniczony przez komórki | |
| FR2988072B1 (fr) | Aeronef | |
| DK3521315T3 (da) | Anti-transglutaminase-2-antistoffer | |
| DK2828292T3 (da) | Jcv-neutraliserende antistoffer | |
| EP2829281A4 (en) | VACCINE AGAINST LIPOPOLYSACCHARIDES (LPS) | |
| DK2935330T3 (da) | Anti-notch3-antistoffer | |
| EP2916694A4 (en) | SPOON | |
| EP2814560A4 (en) | INTERCONNECTS |